skip to main content
Show Results with:

Results 1 - 10 of 11  for Explore Further

results 1 2 next page
Refined by: collection: MEDLINE/PubMed (NLM) remove collection: Scopus (Elsevier) remove author: Joly, Pascal remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

The New England journal of medicine, January 31, 2002, Vol.346(5), pp.321-327 [Peer Reviewed Journal]

No full-text

View all versions
2
Material Type:
Article
Add to My workspace

Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids

Journal of the American Academy of Dermatology, October 2013, Vol.69(4), pp.583-588 [Peer Reviewed Journal]

No full-text

View all versions
3
Material Type:
Article
Add to My workspace

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

The Lancet, 20 May 2017, Vol.389(10083), pp.2031-2040 [Peer Reviewed Journal]

No full-text

View all versions
4
Material Type:
Article
Add to My workspace

Poor benefit/risk balance of intravenous immunoglobulins in DRESS.

Archives of dermatology, April 2012, Vol.148(4), pp.543-544 [Peer Reviewed Journal]

No full-text

View all versions
5
Material Type:
Article
Add to My workspace

Prognostic factors of paraneoplastic pemphigus.

Archives of dermatology, October 2012, Vol.148(10), pp.1165-1172 [Peer Reviewed Journal]

No full-text

View all versions
6
Material Type:
Article
Add to My workspace

Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response

Science translational medicine, 25 August 2010, Vol.2(46), pp.46ra62 [Peer Reviewed Journal]

No full-text

View all versions
7
Material Type:
Article
Add to My workspace

Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.

Science translational medicine, March 6, 2013, Vol.5(175), p.175ra30 [Peer Reviewed Journal]

No full-text

View all versions
8
Material Type:
Article
Add to My workspace

A single cycle of rituximab for the treatment of severe pemphigus.

The New England journal of medicine, August 9, 2007, Vol.357(6), pp.545-552 [Peer Reviewed Journal]

No full-text

View all versions
9
Material Type:
Article
Add to My workspace

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population

Journal of Investigative Dermatology, April 2019, Vol.139(4), pp.835-841 [Peer Reviewed Journal]

No full-text

View all versions
10
Material Type:
Article
Add to My workspace

A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study

Journal of Investigative Dermatology, July 2009, Vol.129(7), pp.1681-1687 [Peer Reviewed Journal]

No full-text

View all versions

Results 1 - 10 of 11  for Explore Further

results 1 2 next page

Refine Search Results

Creation date 

From To
  1. Before2007  (1)
  2. 2007To2008  (1)
  3. 2009To2009  (1)
  4. 2010To2012  (3)
  5. After 2012  (5)
  6. Refine further open sub menu

Try a new search

Ignore my search and look for everything

by this Author/Contributor:

  1. D'Incan, Michel
  2. Joly, Pascal
  3. Delaporte, Emmanuel
  4. Bernard, Philippe
  5. Benichou, Jacques

on this subject:

  1. Medicine
  2. Humans
  3. Aged
  4. Pemphigus
  5. Female

Searching Remote Databases, Please Wait